Cargando…
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855795/ https://www.ncbi.nlm.nih.gov/pubmed/34871181 http://dx.doi.org/10.1172/jci.insight.155483 |
_version_ | 1784653716200095744 |
---|---|
author | Siedner, Mark J. Boucau, Julie Gilbert, Rebecca F. Uddin, Rockib Luu, Jonathan Haneuse, Sebastien Vyas, Tammy Reynolds, Zahra Iyer, Surabhi Chamberlin, Grace C. Goldstein, Robert H. North, Crystal M. Sacks, Chana A. Regan, James Flynn, James P. Choudhary, Manish C. Vyas, Jatin M. Barczak, Amy K. Lemieux, Jacob E. Li, Jonathan Z. |
author_facet | Siedner, Mark J. Boucau, Julie Gilbert, Rebecca F. Uddin, Rockib Luu, Jonathan Haneuse, Sebastien Vyas, Tammy Reynolds, Zahra Iyer, Surabhi Chamberlin, Grace C. Goldstein, Robert H. North, Crystal M. Sacks, Chana A. Regan, James Flynn, James P. Choudhary, Manish C. Vyas, Jatin M. Barczak, Amy K. Lemieux, Jacob E. Li, Jonathan Z. |
author_sort | Siedner, Mark J. |
collection | PubMed |
description | Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections. |
format | Online Article Text |
id | pubmed-8855795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Clinical Investigation |
record_format | MEDLINE/PubMed |
spelling | pubmed-88557952022-02-22 Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections Siedner, Mark J. Boucau, Julie Gilbert, Rebecca F. Uddin, Rockib Luu, Jonathan Haneuse, Sebastien Vyas, Tammy Reynolds, Zahra Iyer, Surabhi Chamberlin, Grace C. Goldstein, Robert H. North, Crystal M. Sacks, Chana A. Regan, James Flynn, James P. Choudhary, Manish C. Vyas, Jatin M. Barczak, Amy K. Lemieux, Jacob E. Li, Jonathan Z. JCI Insight Research Article Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections. American Society for Clinical Investigation 2022-01-25 /pmc/articles/PMC8855795/ /pubmed/34871181 http://dx.doi.org/10.1172/jci.insight.155483 Text en © 2022 Siedner et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Siedner, Mark J. Boucau, Julie Gilbert, Rebecca F. Uddin, Rockib Luu, Jonathan Haneuse, Sebastien Vyas, Tammy Reynolds, Zahra Iyer, Surabhi Chamberlin, Grace C. Goldstein, Robert H. North, Crystal M. Sacks, Chana A. Regan, James Flynn, James P. Choudhary, Manish C. Vyas, Jatin M. Barczak, Amy K. Lemieux, Jacob E. Li, Jonathan Z. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title | Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title_full | Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title_fullStr | Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title_full_unstemmed | Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title_short | Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections |
title_sort | duration of viral shedding and culture positivity with postvaccination sars-cov-2 delta variant infections |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855795/ https://www.ncbi.nlm.nih.gov/pubmed/34871181 http://dx.doi.org/10.1172/jci.insight.155483 |
work_keys_str_mv | AT siednermarkj durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT boucaujulie durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT gilbertrebeccaf durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT uddinrockib durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT luujonathan durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT haneusesebastien durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT vyastammy durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT reynoldszahra durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT iyersurabhi durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT chamberlingracec durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT goldsteinroberth durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT northcrystalm durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT sackschanaa durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT reganjames durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT flynnjamesp durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT choudharymanishc durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT vyasjatinm durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT barczakamyk durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT lemieuxjacobe durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections AT lijonathanz durationofviralsheddingandculturepositivitywithpostvaccinationsarscov2deltavariantinfections |